Metabolomics investigates, characterizes and quantify small molecules (<2000 Da in size) which are produced as part of normal and abnormal metabolism in biological systems. Lipidomics is the equivalent study of lipids (fats). Both show great promise in developing better understanding of the mechanisms and aetiologies of disease processes. In particular, they offer the promise of precision medicine in a veterinary context, enabling better diagnosis, prognosis and disease stratification than is currently possible. 

The Unit for Veterinary Metabolomics was founded in 2025 to promote, improve and develop the use of metabolomics in the clinical veterinary world.  

Towards this end, we are researching better, faster and more robust ways to diagnose disease, predict outcome and stratify subtypes of disease or responses to medication using metabolomics and associated methods. To reach these goals, we are developing new analytical and bioinformatical methodologies and analysing unusual matrices. We focus on mass spectrometry analyses including LC-MS (our major speciality), metabolomic imaging, GC-MS and the development of robust bioinformatic tools for easier quality management and data processing and analysis of metabolomics data. 

We have a specialist focus on the metabolite linkages between organ systems, in particular, the role of the microbiome-metabolome signalling pathway in health, inflammation and infection.  

Our research is highly collaborative; we are delighted for you to contact us if you would like to include metabolomics as part of your research project.